COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.
Expert Rev Mol Med
; 24: e13, 2022 03 15.
Article
em En
| MEDLINE
| ID: mdl-35311631
ABSTRACT
Coronavirus disease 2019 (COVID-19) is associated with autoimmunity and systemic inflammation. Patients with autoimmune rheumatic and musculoskeletal disease (RMD) may be at high risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In this review, based on evidence from the literature, as well as international scientific recommendations, we review the relationships between COVID-19, autoimmunity and patients with autoimmune RMDs, as well as the basics of a multisystemic inflammatory syndrome associated with COVID-19. We discuss the repurposing of pharmaceutics used to treat RMDs, the principles for the treatment of patients with autoimmune RMDs during the pandemic and the main aspects of vaccination against SARS-CoV-2 in autoimmune RMD patients.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Doenças Musculoesqueléticas
/
COVID-19
/
Tratamento Farmacológico da COVID-19
Tipo de estudo:
Guideline
Limite:
Humans
Idioma:
En
Revista:
Expert Rev Mol Med
Assunto da revista:
BIOLOGIA MOLECULAR
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Hungria